{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:35:19Z","timestamp":1792222519282,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40265-022-01742-y","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T13:34:33Z","timestamp":1656423273000},"page":"957-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":512,"title":["Prevention and Treatment of Monkeypox"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-8695","authenticated-orcid":false,"given":"John G.","family":"Rizk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald N.","family":"Forthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"1742_CR1","unstructured":"Monkeypox in Multiple Countries. https:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/monkeypox. Accessed 25 May 2022."},{"key":"1742_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27884","author":"Z Yang","year":"2022","unstructured":"Yang Z. Monkeypox: A potential global threat? [published online ahead of print, 2022 May 25]. J Med Virol. 2022. https:\/\/doi.org\/10.1002\/jmv.27884.","journal-title":"J Med Virol"},{"key":"1742_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00011-17","author":"S Realegeno","year":"2017","unstructured":"Realegeno S, Puschnik AS, Kumar A, et al. Monkeypox virus host factor screen using haploid cells identifies essential role of GARP complex in extracellular virus formation. J Virol. 2017. https:\/\/doi.org\/10.1128\/jvi.00011-17.","journal-title":"J Virol"},{"key":"1742_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10802","author":"J Guarner","year":"2022","unstructured":"Guarner J, Del Rio C, Malani PN. Monkeypox in 2022\u2014what clinicians need to know [published online ahead of print, 2022 Jun 13]. JAMA. 2022. https:\/\/doi.org\/10.1001\/jama.2022.10802.","journal-title":"JAMA"},{"key":"1742_CR5","unstructured":"Durski KN, McCollum AM, Nakazawa Y, et al. Emergence of monkeypox in West Africa and Central Africa, 1970\u20132017. Wkly Epidemiol Rec. 2018;93(11):125\u2013132. Published 2018 Mar 16."},{"key":"1742_CR6","unstructured":"Monkeypox virus infection in the united states and other non-endemic countries\u20142022. https:\/\/emergency.cdc.gov\/han\/2022\/han00466.asp. Accessed 25 May 2022."},{"key":"1742_CR7","unstructured":"CDC and health partners responding to Monkeypox Case in the US. https:\/\/www.cdc.gov\/media\/releases\/2022\/s0518-monkeypox-case.html. Accessed 25 May 2022."},{"key":"1742_CR8","unstructured":"Monkeypox\u2014signs and symptoms. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/symptoms.html. Accessed 25 May 2022."},{"key":"1742_CR9","unstructured":"Centers for Disease Control and Prevention. What clinicians need to know about Monkeypox in the United States and other countries. Accessed 15 June 2022."},{"key":"1742_CR10","unstructured":"Monkeypox\u2014treatment. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html. Accessed 25 May 2022."},{"key":"1742_CR11","unstructured":"Monkeypox: background information. Accessed 15 June 2022."},{"key":"1742_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a011720","author":"DL Heymann","year":"1998","unstructured":"Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull. 1998. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a011720.","journal-title":"Br Med Bull"},{"key":"1742_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/nm1273","author":"E Hammarlund","year":"2005","unstructured":"Hammarlund E, Lewis MW, Carter SV, et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005. https:\/\/doi.org\/10.1038\/nm1273.","journal-title":"Nat Med"},{"key":"1742_CR14","unstructured":"US Centers for Disease Control and Prevention (CDC). Smallpox vaccines. Updated December 2, 2019. https:\/\/www.cdc.gov\/smallpox\/clinicians\/vaccines.html. Accessed 25 May 2022."},{"key":"1742_CR15","unstructured":"FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox. Accessed 25 May 2022."},{"key":"1742_CR16","unstructured":"JYNNEOS [Package Insert]. Kvistg\u00e5rd, Denmark: Bavarian Nordic A\/S: 2019. https:\/\/www.fda.gov\/media\/131078\/download. Accessed 25 May 2022."},{"key":"1742_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/17.3.643","author":"PEM Fine","year":"1988","unstructured":"Fine PEM, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988. https:\/\/doi.org\/10.1093\/ije\/17.3.643.","journal-title":"Int J Epidemiol"},{"key":"1742_CR18","unstructured":"Kupferschmidt K. As monkeypox threat grows, scientists debate best vaccine strategy."},{"key":"1742_CR19","unstructured":"ACAM2000 [Package Insert]. Gaithersburg, MD: Emergent Product Development Gaithersburg Inc 2007. https:\/\/www.fda.gov\/media\/75792\/download. Accessed May 2022."},{"key":"1742_CR20","unstructured":"Vaccines\u2014Smallpox. https:\/\/www.cdc.gov\/smallpox\/clinicians\/vaccines.html. Accessed 25 May 2022."},{"key":"1742_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-017-0165-y","author":"NF Crum-Cianflone","year":"2017","unstructured":"Crum-Cianflone NF, Sullivan E. Vaccinations for the HIV-infected adult: a review of the current recommendations, part II. Infect Dis Ther. 2017. https:\/\/doi.org\/10.1007\/s40121-017-0165-y.","journal-title":"Infect Dis Ther"},{"key":"1742_CR22","doi-asserted-by":"crossref","unstructured":"2022 United States Monkeypox Case. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/outbreak\/current.html. Accessed 25 May 2022.","DOI":"10.1097\/01.NURSE.0000904412.04897.d6"},{"key":"1742_CR23","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6510a2","author":"BW Petersen","year":"2016","unstructured":"Petersen BW, Harms TJ, Reynolds MG, Harrison LH. Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015. MMWR Morb Mortal Wkly Rep. 2016. https:\/\/doi.org\/10.15585\/mmwr.mm6510a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1742_CR24","unstructured":"Monitoring People Who Have Been Exposed. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/monitoring.html. Accessed 25 May 2022."},{"key":"1742_CR25","unstructured":"US Centers for Disease Control and Prevention (CDC). Monkeypox and smallpox vaccine guidance. Updated December 2, 2019. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/smallpox-vaccine.html. Accessed 25 May 2022."},{"key":"1742_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/v9120380","author":"MG Reynolds","year":"2017","unstructured":"Reynolds MG, McCollum AM, Nguete B, Lushima RS, Petersen BW. Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense research. Viruses. 2017. https:\/\/doi.org\/10.3390\/v9120380.","journal-title":"Viruses"},{"key":"1742_CR27","doi-asserted-by":"publisher","unstructured":"Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;S1473\u20133099(22)00228-6. https:\/\/doi.org\/10.1016\/S1473-3099(22)00228-6.","DOI":"10.1016\/S1473-3099(22)00228-6"},{"key":"1742_CR28","unstructured":"TPOXX (tecovirimat) [Package Insert]. Corvallis, OR: SIGA Technologies, Inc. 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/208627s000lbl.pdf. Accessed 25 May 2022."},{"key":"1742_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1819791","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J, et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021. https:\/\/doi.org\/10.1080\/14787210.2020.1819791.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1742_CR30","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1705688","author":"DW Grosenbach","year":"2018","unstructured":"Grosenbach DW, Honeychurch K, Rose EA, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med. 2018. https:\/\/doi.org\/10.1056\/nejmoa1705688.","journal-title":"N Engl J Med"},{"key":"1742_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00879-06","author":"DC Quenelle","year":"2007","unstructured":"Quenelle DC, Buller RML, Parker S, et al. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob Agents Chemother. 2007. https:\/\/doi.org\/10.1128\/AAC.00879-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"1742_CR32","unstructured":"Marcinak J, Vora S, Weber S, et al. Household transmission of vaccinia virus from contact with a military smallpox vaccine\u2014Illinois and Indiana, 2007. Morb Mortal Wkly Rep. 2007."},{"key":"1742_CR33","doi-asserted-by":"publisher","DOI":"10.1086\/587668","author":"S Vora","year":"2008","unstructured":"Vora S, Damon I, Fulginiti V, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis. 2008. https:\/\/doi.org\/10.1086\/587668.","journal-title":"Clin Infect Dis"},{"key":"1742_CR34","doi-asserted-by":"publisher","unstructured":"Hahne S, Macey J, Binnendijk RV, et al. Progressive vaccinia in a military smallpox vaccine\u2014United States, 2009. Pediatr Infect Dis J. 2009. https:\/\/doi.org\/10.1097\/inf.0b013e3181b18ed0","DOI":"10.1097\/inf.0b013e3181b18ed0"},{"key":"1742_CR35","unstructured":"US Food and Drug Administration: FDA approves drug to treat smallpox. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-approves-drug-treat-smallpox. Accessed 25 May 2022."},{"key":"1742_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.01.009","author":"G Chittick","year":"2017","unstructured":"Chittick G, Morrison M, Brundage T, Nichols WG. Short-term clinical safety profile of brincidofovir: a favorable benefit\u2013risk proposition in the treatment of smallpox. Antiviral Res. 2017. https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.009.","journal-title":"Antiviral Res"},{"key":"1742_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/v2122740","author":"R Lanier","year":"2010","unstructured":"Lanier R, Trost L, Tippin T, et al. Development of CMX001 for the treatment of poxvirus infections. Viruses. 2010. https:\/\/doi.org\/10.3390\/v2122740.","journal-title":"Viruses"},{"key":"1742_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/v3010047","author":"AD Rice","year":"2011","unstructured":"Rice AD, Adams MM, Wallace G, et al. Efficacy of CMX001 as a post exposure antiviral in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans. Viruses. 2011. https:\/\/doi.org\/10.3390\/v3010047.","journal-title":"Viruses"},{"key":"1742_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.02.005","author":"S Parker","year":"2012","unstructured":"Parker S, Chen NG, Foster S, et al. Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox\u2014an animal model of smallpox. Antiviral Res. 2012. https:\/\/doi.org\/10.1016\/j.antiviral.2012.02.005.","journal-title":"Antiviral Res"},{"key":"1742_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/095632020801900302","author":"DF Smee","year":"2008","unstructured":"Smee DF. Progress in the discovery of compounds inhibiting orthopoxviruses in animal models. Antivir Chem Chemother. 2008. https:\/\/doi.org\/10.1177\/095632020801900302.","journal-title":"Antivir Chem Chemother"},{"key":"1742_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(02)00196-1","author":"RO Baker","year":"2003","unstructured":"Baker RO, Bray M, Huggins JW. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003. https:\/\/doi.org\/10.1016\/S0166-3542(02)00196-1.","journal-title":"Antiviral Res"},{"key":"1742_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2005.12.001","author":"R Wittek","year":"2006","unstructured":"Wittek R. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J Infect Dis. 2006. https:\/\/doi.org\/10.1016\/j.ijid.2005.12.001.","journal-title":"Int J Infect Dis"},{"key":"1742_CR43","doi-asserted-by":"publisher","DOI":"10.1086\/498155","author":"A Nalca","year":"2005","unstructured":"Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005. https:\/\/doi.org\/10.1086\/498155.","journal-title":"Clin Infect Dis"}],"updated-by":[{"DOI":"10.1007\/s40265-022-01767-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000}}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-022-01742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-022-01742-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-022-01742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:07:29Z","timestamp":1744700849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-022-01742-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1742"],"URL":"https:\/\/doi.org\/10.1007\/s40265-022-01742-y","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"17 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40265-022-01767-3","URL":"https:\/\/doi.org\/10.1007\/s40265-022-01767-3","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None: JGR, GL, BMH, DNF, YR report they have no conflicts of interest to disclose relative to this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is not applicable to this article as no new data were created or analyzed in this study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conception and design: JGR. Writing\u2014original draft: all authors. Writing\u2014review and editing: all authors. Revision for intellectual content: all authors. Final approval of the version to be published: all authors. All authors agree to be accountable for all aspects of the work. All the authors meet the criteria for authorship as per the ICMJE criteria.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}